These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1606880)

  • 41. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology.
    Daniely M; Rona R; Kaplan T; Olsfanger S; Elboim L; Freiberger A; Lew S; Leibovitch I
    Cancer; 2007 Dec; 111(6):517-24. PubMed ID: 17963263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of mailed urine specimens in diagnosing urothelial carcinoma by cytology and DNA image analysis.
    Liu J; Katz R; Shin HJ; Johnston DA; Zhang HZ; Caraway NP
    Acta Cytol; 2005; 49(2):157-62. PubMed ID: 15839620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of the Cytomorphological Features in Atypical Urine Specimens following Application of The Paris System for Reporting Urinary Cytology.
    Glass R; Rosen L; Chau K; Sheikh-Fayyaz S; Farmer P; Coutsouvelis C; Slim F; Brenkert R; Das K; Raab S; Cocker R
    Acta Cytol; 2018; 62(1):54-61. PubMed ID: 29151086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytologic and histopathologic study of bladder cancer patients.
    Friedell GH; Soto EA; Nagy GK
    Urol Clin North Am; 1976 Feb; 3(1):71-8. PubMed ID: 936369
    [No Abstract]   [Full Text] [Related]  

  • 45. Cytology of lleal conduit urine in bladder cancer patients: diagnostic utility and pitfalls.
    Ajit D; Dighe SB; Desai SB
    Acta Cytol; 2006; 50(1):70-3. PubMed ID: 16514843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The value of exfoliative cytology of the urine in the diagnosis of bladder tumors].
    Maier U; Kuber W; Krepler R
    Onkologie; 1980 Dec; 3(6):276-77. PubMed ID: 7012724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer.
    Priolo G; Gontero P; Martinasso G; Mengozzi G; Formiconi A; Pelucelli G; Zitella A; Casetta G; Viberti L; Aimo G; Tizzani A
    Clin Chim Acta; 2001 Mar; 305(1-2):47-53. PubMed ID: 11249922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [What is the value of urine cytology in after-care of patients with urothelial cancers?].
    Möllhoff S; Rathert P
    Urologe A; 1992 Jul; 31(4):203-5. PubMed ID: 1514198
    [No Abstract]   [Full Text] [Related]  

  • 49. Growth promotion of urothelial cells by a silk suture in the bladder walls of rats.
    Shimamura T
    Acta Pathol Jpn; 1987 Feb; 37(2):273-80. PubMed ID: 3604679
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Exfoliative cytology of bladder tumors--diagnostic place of the sediment chamber technic in relation to cytochemical findings].
    Gorski J; Weisshaar F
    Arch Geschwulstforsch; 1987; 57(3):187-93. PubMed ID: 3619590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
    Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
    Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of a single dose of cyclophosphamide. V. Protective effect of diversion of the urinary stream on dog bladder.
    Bellin HJ; Cherry JM; Koss LG
    Lab Invest; 1974 Jan; 30(1):43-7. PubMed ID: 4812807
    [No Abstract]   [Full Text] [Related]  

  • 53. [Excretion of beta-2-microglobulin and Tamm-Horsfall protein in patients undergoing a conditioning regimen before bone marrow transplantation].
    Franek E; Kokot F; Wojnar J; Wacławik A; Duława J; Wiecek A; Markiewicz M; Hołowiecki J
    Pol Arch Med Wewn; 1994 Nov; 92(5):381-6. PubMed ID: 7885985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The cytomorphological features of low-grade urothelial neoplasms vary by specimen type.
    Zhang ML; Rosenthal DL; VandenBussche CJ
    Cancer Cytopathol; 2016 Aug; 124(8):552-64. PubMed ID: 27019161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bladder tumour control by abdominal ultrasound and urine cytology.
    Juul N; Torp-Pedersen S; Larsen S; Rasmussen F; Holm HH
    Scand J Urol Nephrol; 1986; 20(4):275-8. PubMed ID: 3544204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of bladder washings and urine cytology in the diagnosis of bladder cancer.
    Trott PA; Edwards L
    J Urol; 1973 Dec; 110(6):664-6. PubMed ID: 4757548
    [No Abstract]   [Full Text] [Related]  

  • 57. The early changes in the development of bladder cancer in patients exposed to known industrial carcinogens.
    Glashan RW; Wijesinghe DP; Riley A
    Br J Urol; 1981 Dec; 53(6):571-7. PubMed ID: 7317744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity.
    Hassan M; Ljungman P; Ringdén O; Hassan Z; Oberg G; Nilsson C; Békassy A; Bielenstein M; Abdel-Rehim M; Georén S; Astner L
    Bone Marrow Transplant; 2000 May; 25(9):915-24. PubMed ID: 10800057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The Paris system for classification of urinary cytology].
    Savic S; Vlajnic T; Bubendorf L
    Pathologe; 2017 Sep; 38(5):451-462. PubMed ID: 28791453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.